264 related articles for article (PubMed ID: 24997771)
21. Clinical and genetic features of patients with multiple endocrine tumors who have neither family history nor MEN1 germline mutations.
Sakurai A; Katai M; Yumita W; Minemura K; Hashizume K
Endocrine; 2004 Feb; 23(1):45-9. PubMed ID: 15034196
[TBL] [Abstract][Full Text] [Related]
22. The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations.
Ozawa A; Agarwal SK; Mateo CM; Burns AL; Rice TS; Kennedy PA; Quigley CM; Simonds WF; Weinstein LS; Chandrasekharappa SC; Collins FS; Spiegel AM; Marx SJ
J Clin Endocrinol Metab; 2007 May; 92(5):1948-51. PubMed ID: 17299066
[TBL] [Abstract][Full Text] [Related]
23. Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1.
Loffler KA; Biondi CA; Gartside M; Waring P; Stark M; Serewko-Auret MM; Muller HK; Hayward NK; Kay GF
Int J Cancer; 2007 Jan; 120(2):259-67. PubMed ID: 17044021
[TBL] [Abstract][Full Text] [Related]
24. Metabolic expressivity of human genetic variants: NMR metabotyping of MEN1 pathogenic mutants.
Blaise BJ; Lopez C; Vercherat C; Lacheretz-Bernigaud A; Bayet-Robert M; Rezig L; Scoazec JY; Calender A; Emsley L; Elena-Herrmann B; Cordier-Bussat M
J Pharm Biomed Anal; 2014 May; 93():118-24. PubMed ID: 24183932
[TBL] [Abstract][Full Text] [Related]
25. Menin missense mutants associated with multiple endocrine neoplasia type 1 are rapidly degraded via the ubiquitin-proteasome pathway.
Yaguchi H; Ohkura N; Takahashi M; Nagamura Y; Kitabayashi I; Tsukada T
Mol Cell Biol; 2004 Aug; 24(15):6569-80. PubMed ID: 15254225
[TBL] [Abstract][Full Text] [Related]
26. Asymptomatic children with multiple endocrine neoplasia type 1 mutations may harbor nonfunctioning pancreatic neuroendocrine tumors.
Newey PJ; Jeyabalan J; Walls GV; Christie PT; Gleeson FV; Gould S; Johnson PR; Phillips RR; Ryan FJ; Shine B; Bowl MR; Thakker RV
J Clin Endocrinol Metab; 2009 Oct; 94(10):3640-6. PubMed ID: 19622622
[TBL] [Abstract][Full Text] [Related]
27. Novel Germline c.105_107dupGCT
Stasiak M; Dedecjus M; Zawadzka-Starczewska K; Adamska E; Tomaszewska M; Lewiński A
Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32847108
[TBL] [Abstract][Full Text] [Related]
28. New therapies for patients with multiple endocrine neoplasia type 1.
Geslot A; Vialon M; Caron P; Grunenwald S; Vezzosi D
Ann Endocrinol (Paris); 2021 Apr; 82(2):112-120. PubMed ID: 33839123
[TBL] [Abstract][Full Text] [Related]
29. A Novel Germline c.1267T>A
Gierlikowski W; Skwarek-Szewczyk A; Popow M
Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33233395
[TBL] [Abstract][Full Text] [Related]
30. Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers.
Machens A; Schaaf L; Karges W; Frank-Raue K; Bartsch DK; Rothmund M; Schneyer U; Goretzki P; Raue F; Dralle H
Clin Endocrinol (Oxf); 2007 Oct; 67(4):613-22. PubMed ID: 17590169
[TBL] [Abstract][Full Text] [Related]
31. MEN1 and pituitary adenomas.
Delemer B
Ann Endocrinol (Paris); 2012 Apr; 73(2):59-61. PubMed ID: 22542456
[TBL] [Abstract][Full Text] [Related]
32. Multiple endocrine neoplasia type 1 (MEN1).
Thakker RV
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):355-70. PubMed ID: 20833329
[TBL] [Abstract][Full Text] [Related]
33. Multiple endocrine neoplasia type 1 (MEN1) in Austria.
Weinhäusel A; Kaserer K; Vierhapper H; Niederle B; Haas OA;
Wien Klin Wochenschr; 2002 Apr; 114(7):252-7. PubMed ID: 12089860
[TBL] [Abstract][Full Text] [Related]
34. Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene.
Lemos MC; Thakker RV
Hum Mutat; 2008 Jan; 29(1):22-32. PubMed ID: 17879353
[TBL] [Abstract][Full Text] [Related]
35. New splicing mutation of MEN1 gene affecting the translocation of menin to the nucleus.
Tala HP; Carvajal CA; González AA; Garrido JL; Tobar J; Solar A; Campino C; Arteaga E; Fardella CE
J Endocrinol Invest; 2006 Nov; 29(10):888-93. PubMed ID: 17185897
[TBL] [Abstract][Full Text] [Related]
36. Accelerated proliferation and differential global gene expression in pancreatic islets of five-week-old heterozygous Men1 mice: Men1 is a haploinsufficient suppressor.
Lejonklou MH; Barbu A; Stålberg P; Skogseid B
Endocrinology; 2012 Jun; 153(6):2588-98. PubMed ID: 22492302
[TBL] [Abstract][Full Text] [Related]
37. Association between the p27 rs2066827 variant and tumor multiplicity in patients harboring MEN1 germline mutations.
Longuini VC; Lourenço DM; Sekiya T; Meirelles O; Goncalves TD; Coutinho FL; Francisco G; Osaki LH; Chammas R; Alves VA; Siqueira SA; Schlesinger D; Naslavsky MS; Zatz M; Duarte YA; Lebrão ML; Gama P; Lee M; Molatore S; Pereira MA; Jallad RS; Bronstein MD; Cunha-Neto MB; Liberman B; Fragoso MC; Toledo SP; Pellegata NS; Toledo RA
Eur J Endocrinol; 2014 Sep; 171(3):335-42. PubMed ID: 24920291
[TBL] [Abstract][Full Text] [Related]
38. Increased menin expression in sporadic pituitary adenomas.
Wrocklage C; Gold H; Hackl W; Buchfelder M; Fahlbusch R; Paulus W
Clin Endocrinol (Oxf); 2002 May; 56(5):589-94. PubMed ID: 12030908
[TBL] [Abstract][Full Text] [Related]
39. Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database.
Marini F; Giusti F; Fossi C; Cioppi F; Cianferotti L; Masi L; Boaretto F; Zovato S; Cetani F; Colao A; Davì MV; Faggiano A; Fanciulli G; Ferolla P; Ferone D; Loli P; Mantero F; Marcocci C; Opocher G; Beck-Peccoz P; Persani L; Scillitani A; Guizzardi F; Spada A; Tomassetti P; Tonelli F; Brandi ML
Endocrine; 2018 Oct; 62(1):215-233. PubMed ID: 29497973
[TBL] [Abstract][Full Text] [Related]
40. MEN1 935-1G>C splicing mutation in an Indian patient with multiple endocrine neoplasia type 1.
Raghavan R; Shah S; Kondkar AA; Dherai AJ; Desai D; Chauhan P; Lala M; Ashavaid TF
Mol Diagn Ther; 2007; 11(2):129-31. PubMed ID: 17397250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
